Veranova

Veranova is a global leader in the development and manufacturing of specialty and complex active pharmaceutical ingredients (APIs) for pharma and biotech customers. The company has collaborated with 18% of FDA-approved small molecule drugs since 2014 and maintains 200+ active Drug Master Files (DMFs) with 2,500+ completed solid form projects across structurally diverse and complex APIs.

Core Capabilities

Solid Form & Particle Engineering

• Amorphous solid dispersion development
• Chiral resolution and confirmation
• Crystallization development
• Enabling formulation
• Particle size modification
• Physicochemical and solid form profiling
• Polymorph, salt, and cocrystal screening
• Spray drying
• Structure confirmation

Process and Analytical Development

• Analytical method development
• Process development
• Separations and purifications
• Technology transfer
• Green chemistry

Custom API Manufacturing

• Multi-scale clinical and commercial APIs
• Highly potent APIs
• Controlled substance manufacturing

Specialty Modalities

• ADCs: linkers, payloads, and conjugates
• PEGs and lipids
• PROTACs (proteolysis targeting chimeras)
• TIDES: nucleotides, oligonucleotides, and peptides

Quality, Compliance & Regulatory Affairs

• API life cycle management
• Reference standards
• Generic API products

Veranova operates with a collaborative, consultative approach to support innovation from development through commercial scale-up, with emphasis on flexibility, agility, and supply chain management.